Lockheed Martin: Buy the Q3 Lift — Trade Plan to Ride Momentum Around a $292B Backlog

Hook / Thesis

Lockheed Martin just delivered a clean Q3 beat and, crucially, a record backlog of $291.98 billion. That backlog - anchored by accelerating missile production and a multiyear award in missile interceptors - changes the near-term revenue profile and gives management visibility to lift 2026 guidance to $80-$82 billion. For traders, this is a clear catalyst-led setup: fundamentals that justify higher multiples plus momentum in price and volume create an actionable swing trade with defined risk.

My short-term stance is bullish: buy a disciplined entry near the current price to capture follow-through into the next tranche of defense awards and the next re-rating window. The plan below gives an exact entry, stop and target with a horizon of the mid-term swing window - 45 trading days - to ride momentum while avoiding exposure to longer-term program execution risk.

What Lockheed Martin Does and Why Investors Should Care

Lockheed Martin is a diversified defense prime operating four core segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The company designs, manufactures and sustains advanced military systems including the F-35, missile systems, radars, helicopters and satellites. The near-term story is not a single jet or satellite but rising munition and missile volumes plus multiyear awards that convert into backlog and predictable revenue over several years.

Why the market should care: a near-$292B backlog provides revenue visibility and is a tangible buffer against cyclical defense budgets. Combined with a raised 2026 sales guide ($80-$82B) and an adjusted EPS outlook of $30.35-$30.75, Lockheed just gave investors a clearer path to earnings growth and free cash flow conversion.

Numbers That Matter

• Q3 2026 adjusted EPS: $7.97, a beat of roughly 6.4% versus consensus.
• Q3 2026 sales: $20.71 billion, up 11.3% year-over-year.
• Record backlog: $291.98 billion.
• 2026 guidance upgraded to $80 - $82 billion in sales; adjusted EPS guidance raised to $30.35 - $30.75.
• Free cash flow (trailing): $8.381 billion.
• Market snapshot: share price near $635.31, market cap about $146.8 billion, trailing P/E roughly 21.5x.

Valuation Framing

At a market cap near $146.8B and a consensus-style trailing EPS level implied by management targets, Lockheed trades around 21x earnings today. That multiple is within historical ranges for large defense primes, especially when growth is visible: management raised sales and EPS guidance and projects high-single-digit revenue growth into 2027 across segments. The company also yields roughly 2.3% from dividends and generates north of $8B in free cash flow, supporting both buybacks and dividends.

Qualitatively, the valuation is palatable given the defensive revenue stream from backlog and large, long-duration programs. The counterpoint is margin pressure risks as production scales (notably F-35 bulk rate) and capital intensity rising, which can compress free cash flow. Still, with backlog converting to revenue in coming years and strong missile demand, the current multiple is priced for solid but not extraordinary execution - leaving room for upside if program margins hold.

Technical / Sentiment Picture

• Price momentum: strong — the stock is trading above its 10-, 20-, and 50-day averages with MACD showing bullish momentum.
• RSI: elevated at 82.7 (overbought), signaling caution on immediate rallies and the potential for short-term pullbacks.
• Volume: intraday and recent volume have been elevated versus the 30-day average, indicating firm institutional participation.

Trade Plan (Actionable)

Rationale: enter at $632 to capture momentum while allowing a small buffer below the recent support cluster and intra-session volatility. The stop at $590 limits downside if momentum reverses or if broader defense sentiment turns negative. The target of $720 is a realistic, catalyst-driven re-rating within a 45-trading-day swing given upgraded guidance, continuing award flow and analyst price target repricing (some firms raised targets into the $620-$835 range after earnings).

Position sizing: keep the trade a defined slice of risk capital (for most traders 1-3% of portfolio risk). If price gaps through the entry on news, use the next available execution price but maintain the $590 stop intact relative to your new cost basis.

Catalysts to Watch (2-5)

• Follow-on contract announcements and awards, especially additional missile or PAC-3 style deals; these directly feed backlog and revenue conversion.
• Analyst re-ratings and price target updates in the weeks after Q3 — upgrades can accelerate flows.
• Macro moves in Treasury yields and defense budgets - lower yields and supportive budget language typically help defense primes.
• Quarterly trading updates or segment-level order announcements that confirm accelerated production rates.

Risks and Counterarguments

• Margin Compression Risk - higher volumes, especially if F-35 production scales up at bulk rates, can compress margins. Management warned this dynamic may increase unit costs or require heavier capital spending to ramp capacity.
• Execution Risk - big defense programs have multi-year execution risks. Cost overruns or schedule slips reduce near-term margins and cash flow.
• Free Cash Flow Pressure - while FCF is strong historically ($8.381B), rising capital expenditures have already depressed FCF year-over-year in recent commentary. A sharp rise in capex or working capital needs could limit buybacks/dividends and pressure the multiple.
• Valuation Heat - the stock is extended technically (RSI ~82.7). Short-term profit-taking or a broad market pullback could trigger a correction even with good fundamentals.
• Geopolitical / Budget Risk - defense spending is political. Changes in U.S. procurement priorities or international partner budgets could affect award cadence.

Counterargument: one could argue that the best entry isn't now because the stock is technically overbought and multiple analysts have warned about margin compression at scale. If you accept that production rate-driven margin pressure is likely and that capital intensity will rise, the current multiple might already bake in too much optimism. That is a legitimate view — it supports waiting for a pullback toward the 50-day moving average as a lower-risk entry.

What Would Change My Mind

I'd abandon this bullish swing if any of the following occur: 1) management withdraws or cuts 2026 guidance; 2) a material program-report of cost overruns or schedule slippage (particularly on F-35 or major space programs); 3) free cash flow guidance materially misses and capital returns are curtailed; or 4) a macro-driven slump in defense budgets or a sudden rise in Treasury yields that pressures multiples across the defense sector.

Bottom Line / Conclusion

Lockheed Martin's Q3 results and a near-$292B backlog create a compelling, catalyst-rich environment for a mid-term swing trade. The company combined tangible order flow with upwardly revised guidance and continued strong free cash flow generation. The trade outlined here - buy at $632, stop at $590, target $720 over ~45 trading days - balances upside capture and defined risk. That said, technical overextension and margin execution risks argue for strict stops and prudent sizing. If you prefer lower volatility, waiting for a pullback toward the 50-day moving average is a reasonable alternative.

Quick Reference Metrics

Trade idea: Buy $632.00, stop $590.00, target $720.00, horizon mid term (45 trading days). Manage size and respect the stop.